Protocol for a Multicentre Survey of Patients With Treatment Resistant Hypertension
NCT ID: NCT03078244
Last Updated: 2018-02-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1500 participants
OBSERVATIONAL
2016-11-30
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Resistant Arterial Hypertension Cohort Study
NCT01083017
National Survey on Hypertension at Hospital
NCT00695266
National Survey on Hypertension in Cardiologic Private Practice
NCT00695175
National Survey on Hypertension in General Practitioner (GP) Consultation
NCT00695656
Retrospective Treatment Pattern Survey for the Patients With Hypertension and Stroke
NCT00681707
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
N/A, observational study
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No known secondary cause of hypertension
* History of uncontrolled hypertension while using 3 or more anti-hypertensive agents
* Controlled blood pressure using 4 or more different anti-hypertensive agents
Exclusion Criteria
18 Years
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The George Institute
OTHER
Actelion
INDUSTRY
Emerald Clinical Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ACHT41
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.